- Investing Ideas
- /
- Chinese Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Chinese Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Results
7
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
7 companies
WuXi AppTec
Market Cap: CN¥151.1b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥52.85
7D
1.4%
1Y
25.2%
Sichuan Kelun Pharmaceutical
Market Cap: CN¥53.7b
Researches, develops, manufactures, distributes, and sells pharmaceutical products in China.
002422
CN¥33.93
7D
-4.9%
1Y
15.8%
Pacific Shuanglin Bio-pharmacy
Market Cap: CN¥16.4b
Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in research, development, production, and sales of blood products in China.
000403
CN¥22.50
7D
-8.9%
1Y
-25.0%
Henan Lingrui Pharmaceutical
Market Cap: CN¥12.8b
Produces and sells medicines in China.
600285
CN¥22.81
7D
0.8%
1Y
-2.9%
Guobang Pharma
Market Cap: CN¥10.4b
Engages in the research, development, production, and sale of products in the pharmaceutical and veterinary industries.
605507
CN¥18.71
7D
-5.1%
1Y
16.8%
Hunan Jiudian Pharmaceutical
Market Cap: CN¥8.2b
Researches, develops, produces, and sells pharmaceutical products in China and internationally.
300705
CN¥16.46
7D
-2.1%
1Y
-33.2%
Guizhou Sanli PharmaceuticalLtd
Market Cap: CN¥5.0b
GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products.
603439
CN¥12.51
7D
0%
1Y
-14.8%